https://www.selleckchem.com/pr....oducts/incb054329.ht
6%, respectively ( 0.001). Age (HR per year = 1.04 (1.02, 1.05), 0.001), female gender (HR = 1.56 (1.12, 2.16), = 0.008), diabetes (HR = 1.49 (1.07, 2.06), = 0.02), eccentric hypertrophy (HR = 1.58 (1.006, 2.47), = 0.047), peak troponin I (HR per 1 ng/ml = 1.004 (1.001, 1.006), = 0.004) and left ventricular ejection fraction 50% (HR = 1.57 (1.12, 2.2, 0.008) were significant predictors of MACE. The presence of eccentric hypertrophy in ACS patients undergoing PCI is an independent predictor of adverse outcomes at